Yes. You get the points...and remind of the enormous intrinsic value of the technology and the ongoing building of a fantastic pipeline of additional drugs.
Prof. Zee Upton and her team had made the discovery. BeIng an outstandIng scIentIst, she dreamed a solution to existing medical illnessses, she built a great team in QUT and advanced to a point where she realized the technology had to be marketed. QUT, one of our foundIng shareholders with close to 8 million shares, assisted in the initial listing and is still with us.
it is a blockbuster technology, quite unique for its versatility and the proof stays with the current building of a potential large pipeline.
Isaac Newton said that the truth is in simplicity, and not in the multiplicity and complexity of things.
We have found simplicity, so we are on the road for a major price appreciation as FTT raise the foundation stones of a major skyscraper.
You will see.
The smart investor are those that understand where is value. Here beside the incredible outstanding technology, we have an outstanding team. The research team is top of the class as the CEO and the member of the Board. There are all here for a major appreciation and not for few cents. We speak of $1 increments. Some billion dollar valuations are next, as partners, VLU Phase III, EU certification, DFU Phase II, Ocular FDA Orphan Drug Phase I, New patents on VF000X conquest their successes.
FTT Price at posting:
8.0¢ Sentiment: Buy Disclosure: Held